195 related articles for article (PubMed ID: 11559822)
1. Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer.
Hillgenberg M; Tönnies H; Strauss M
J Virol; 2001 Oct; 75(20):9896-908. PubMed ID: 11559822
[TBL] [Abstract][Full Text] [Related]
2. System for efficient helper-dependent minimal adenovirus construction and rescue.
Hillgenberg M; Schnieders F; Löser P; Strauss M
Hum Gene Ther; 2001 Apr; 12(6):643-57. PubMed ID: 11426464
[TBL] [Abstract][Full Text] [Related]
3. Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors.
Keriel A; René C; Galer C; Zabner J; Kremer EJ
J Virol; 2006 Feb; 80(3):1487-96. PubMed ID: 16415025
[TBL] [Abstract][Full Text] [Related]
4. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
[TBL] [Abstract][Full Text] [Related]
5. AAV serotype 2 vectors preferentially integrate into active genes in mice.
Nakai H; Montini E; Fuess S; Storm TA; Grompe M; Kay MA
Nat Genet; 2003 Jul; 34(3):297-302. PubMed ID: 12778174
[TBL] [Abstract][Full Text] [Related]
6. Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA.
Stephen SL; Sivanandam VG; Kochanek S
J Gene Med; 2008 Nov; 10(11):1176-89. PubMed ID: 18773501
[TBL] [Abstract][Full Text] [Related]
7. Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters.
Mittal SK; Bett AJ; Prevec L; Graham FL
Virology; 1995 Jun; 210(1):226-30. PubMed ID: 7793076
[TBL] [Abstract][Full Text] [Related]
8. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
[TBL] [Abstract][Full Text] [Related]
9. Frequency and stability of chromosomal integration of adenovirus vectors.
Harui A; Suzuki S; Kochanek S; Mitani K
J Virol; 1999 Jul; 73(7):6141-6. PubMed ID: 10364373
[TBL] [Abstract][Full Text] [Related]
10. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector.
Hersh J; Crystal RG; Bewig B
Gene Ther; 1995 Mar; 2(2):124-31. PubMed ID: 7719929
[TBL] [Abstract][Full Text] [Related]
11. Transient foamy virus vector production by adenovirus vectors.
Russell RA; Vassaux G; Martin-Duque P; McClure MO
Gene Ther; 2004 Feb; 11(3):310-6. PubMed ID: 14737091
[TBL] [Abstract][Full Text] [Related]
12. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
[TBL] [Abstract][Full Text] [Related]
13. Retrotransposon-adenovirus hybrid vectors: efficient delivery and stable integration of transgenes via a two-stage mechanism.
Soifer HS; Kasahara N
Curr Gene Ther; 2004 Dec; 4(4):373-84. PubMed ID: 15578988
[TBL] [Abstract][Full Text] [Related]
14. An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus.
Maione D; Della Rocca C; Giannetti P; D'Arrigo R; Liberatoscioli L; Franlin LL; Sandig V; Ciliberto G; La Monica N; Savino R
Proc Natl Acad Sci U S A; 2001 May; 98(11):5986-91. PubMed ID: 11353820
[TBL] [Abstract][Full Text] [Related]
15. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
16. Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector.
Soifer H; Higo C; Kazazian HH; Moran JV; Mitani K; Kasahara N
Hum Gene Ther; 2001 Jul; 12(11):1417-28. PubMed ID: 11485633
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.
Fisher KJ; Choi H; Burda J; Chen SJ; Wilson JM
Virology; 1996 Mar; 217(1):11-22. PubMed ID: 8599194
[TBL] [Abstract][Full Text] [Related]
18. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
19. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
20. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
